US: Akorn, VersaPharm tie-up cleared with conditions (Competition Policy International)

· 1 min read · Global Blogs

The US Federal Trade Commission said Monday it has approved of the proposed merger between pharmaceutical companies VersaPharm and Akorn, but has imposed conditions on the transaction.

Akorn plans to acquire VersaPharm in a $440 million deal first announced in May; the deal will expand Akorn’s drug marketing and development operations.

The …read more

Source: Global Competition Law Blogs

Cite this post

OSCOLA

21st Century Competition, 'US: Akorn, VersaPharm tie-up cleared with conditions (Competition Policy International)' (21st Century Competition, 5 August 2014) <https://www.twentyfirstcenturycompetition.com/2014/08/us-akorn-versapharm-tie-up-cleared-with-conditions-competition-policy-international/> accessed 8 April 2026.

Chicago

21st Century Competition. "US: Akorn, VersaPharm tie-up cleared with conditions (Competition Policy International)." 21st Century Competition, 5 August 2014. https://www.twentyfirstcenturycompetition.com/2014/08/us-akorn-versapharm-tie-up-cleared-with-conditions-competition-policy-international/.

BibTeX

@misc{21st-century-competition2014, author = {21st Century Competition}, title = {{US: Akorn, VersaPharm tie-up cleared with conditions (Competition Policy International)}}, year = {2014}, url = {https://www.twentyfirstcenturycompetition.com/2014/08/us-akorn-versapharm-tie-up-cleared-with-conditions-competition-policy-international/}, note = {21st Century Competition} }
Download .bib file

Related Posts